对比上年同期，公司保健品板块2025年营业收入有所下降，导致本报告期归属于母公司所有者的净利润 同比下降。 公司预计2025年年度实现归属于母公司所有者的扣除非经常性损益后的净利润约为-700万元，与上年同 期相比，预计将减少约1,281万元，同比下降约220%。（未经审计） 格隆汇1月27日丨交大昂立（维权）(600530.SH)公布，公司预计2025年年度实现归属于母公司所有者的 净利润约为450万元，与上年同期相比，预计将减少约2,598万元，同比下降约85%。（未经审计） ...

人民财讯1月27日电，交大昂立（600530）1月27日发布业绩预告，预计2025年净利润450万元，同比下 降约85%。对比上年同期，公司保健品板块2025年营业收入有所下降，导致本报告期归属于母公司所有 者的净利润同比下降。 ...

市场监管总局价监竞争局一级巡视员杨洪丰表示，针对私域直播虚假宣传乱象，市场监管部门持续强化 民生领域反不正当竞争工作，严厉打击此类违法违规行为，取得积极成效。 首先是部署全国市场监管系统开展专项整治。去年印发《关于开展老年人药品、保健品虚假宣传专项整 治的通知》，部署全国市场监管部门严查老年人药品、保健品虚假宣传、价格欺诈、违法广告等侵害老 年人合法权益、破坏养老服务市场竞争秩序的行为。专项整治工作期间，征集群众及经营主体提供的问 题线索9268个，查办违法案件6175件，罚没金额1.035亿元，责令4908家主体整改、涉及金额634.77万 元，向纪检监察机关移送违规违纪线索134条，取得阶段性整治成果。 其次是加强监管执法，全链条打击违法行为。针对保健品虚假宣传违法行为向私域直播领域蔓延发展、 规避监管的趋势，市场监管部门开展靶向治理，成立专门工作机制，全程跟进指导督办，对相关私域直 播平台开展起底核查，查处了一批违法违规的私域直播平台、私域直播间、相关产品生产企业、销售企 业等违法主体，实现了全链条打击。 此外，压实平台责任，推动对违法行为的治理关口前移。针对一些不法商家利用私域群聊诱导消费者进 入私域 ...

经济观察网 据央视新闻客户端消息，记者今天从市场监管总局召开的2025年综合整治"内卷式"竞争十 大重大案件发布会上了解到，针对整治网络不正当竞争行为助长"内卷"乱象，损害消费者利益，市场监 管总局部署开展2025年整治网络不正当竞争行为专项行动。聚焦党中央关心、人民群众关注、违法行为 高发的直播电商、老年人药品、保健品、光伏、汽车、平台等重点领域、行业，加大对流量劫持、非法 获取数据、直播带货中商业诋毁、刷单炒信、夸大产品功效、虚构直播间人气、光伏、汽车、平台等领 域互黑互踩以及人工智能领域不正当竞争等各类违法行为的查处力度。2025年全国共查办各类网络不正 当竞争案件1932件，罚没金额7152.94万元。 ...

（文章来源：每日经济新闻） 每经AI快讯，1月27日，据市场监管总局消息，2025年全国共查办各类网络不正当竞争案件1932件，罚 没金额7152.94万元。据介绍，2025年，市场监管总局部署开展整治网络不正当竞争行为专项行动，聚 焦直播电商、保健品、光伏等重点领域，对流量劫持、非法获取数据、直播带货中商业诋毁、人工智能 领域不正当竞争等各类违法行为加大查处力度。 ...

连续六年获得来自权威机构的持续认可，源于无限极对人才的长期投入与实践。通过秉持"永远创业"的企业价值 观，持续打造充满活力、不断成长的团队。 在本年度的认证中，以下3个方面获得了杰出雇主调研机构的重点肯定： 员工是企业的根基，也是服务市场、传递用户价值的关键纽带。一支健康、快乐的员工队伍，才能持续为市场和 用户提供更优质的产品与服务，帮助更多人更健康、更快乐。正是这份对员工的重视与投入，让无限极在打造卓 越职场的道路上不断收获认可——2026年1月15日，杰出雇主调研机构（Top Employers Institute）公布了一年一度 的杰出雇主榜单，无限极再度上榜，成功获得"2026中国杰出雇主"认证。这是无限极连续第六年将这份殊荣捧回 家。 你或许会好奇：怎样的职场环境，才能持续获得权威机构的认可？"六连冠"的背后，是一份经得起国际标准年复 一年严苛审视的扎实答卷，更是一段关于"如何以企业文化为引领，与员工一起共创更健康、更快乐职场环境"的 温暖故事。 "杰出雇主"是由杰出雇主调研机构主办的权威认证，全球统一认证标准，由独立第三方机构审核，从六大领域， 20个话题，全方位评估企业的人力资源实践。 通过严苛 ...

提起琳琅满目的保健品，维生素是比较"出圈"的，甚至还培养出了明星级系列产品。近几年，"辅酶 Q10"也屡屡被提及，在很多拥趸眼里，它是名副其实的"护心灵药"。但是，也有人表示吃完辅酶Q10没 见什么积极效果，不过是"智商税"而已。实际情况到底如何呢？ 国外对辅酶Q10常见功能的表述要更全面一些，包括保护心脏健康、辅助补充各种原因造成的辅酶Q10 减少、抗氧化、缓解疲劳等作用。至于正常人通过补充辅酶Q10能否有效预防心血管疾病的发生还有待 研究。 查阅药品说明书不难发现，辅酶Q10可用于病毒性心肌炎、慢性心功能不全、病毒性肝炎等的辅助治 疗，还能减轻癌症患者因放疗、化疗引起的某些不良反应。 它是人体必需的化合物 辅酶Q10为脂溶性物质，类似于维生素（也被叫做维生素Q）。 辅酶Q10是人体必需的化合物，主要参与能量代谢，就像"充电宝"，维持各种细胞的正常生理活动。在 能量消耗较多的器官，如心脏、肝脏、肾脏中分布更为普遍，以心脏中的浓度最高。 人体内辅酶Q10的总含量在500至1500毫克，其中3/4都是通过自身合成的，另外1/4来自饮食（肉、奶、 鱼的辅酶Q10含量比较高，其次是植物油和蔬菜等）。而随着年龄的增长 ...

Group 1: AI Industry Insights - Baidu and Tencent are launching cash red envelope promotions to boost AI application usage during the Spring Festival, with Baidu offering 500 million yuan and Tencent 1 billion yuan in total rewards, potentially increasing AI application frequency across the industry [2] - The NAND flash memory prices have surged over 100% in Q1 2026, exceeding market expectations, as Samsung Electronics has completed supply contract negotiations, indicating a strong recovery in the storage industry [3] Group 2: Company Performance Forecasts - Sitway (688213.SH) expects 2025 revenue between 8.8 billion to 9.2 billion yuan, a year-on-year increase of 47% to 54%, with net profit projected at approximately 980 million to 1.03 billion yuan, reflecting a growth of 149% to 162% [4] - Bailong Chuangyuan reported a 2025 revenue of 1.379 billion yuan, up 19.75% year-on-year, and a net profit of 366 million yuan, up 48.94%, driven by product structure optimization and high-margin product prioritization [10] - Qingsong Co. forecasts 2025 revenue of about 2.22 billion yuan, a 14% increase, with net profit expected to grow 1.4 to 2 times, attributed to a strategic focus on high-margin cosmetics ODM business [11] - Rongjie Health anticipates a net profit of 75 to 88 million yuan in 2025, representing a growth of 60% to 88%, driven by the strong performance of health products, particularly high-margin infrared therapy sauna rooms [12]

Group 1 - The core point of the article is that multiple listed companies, including Furi Co., are launching shareholder reward activities to enhance investor relations and provide incentives for holding shares [1][2][4][5] Group 2 - Furi Co. announced a shareholder reward activity where shareholders holding 10000 shares or more as of January 21 can participate [1][3] - Shareholders with 200,000 shares or more will receive gift boxes valued at 5000 yuan, while those with 10,000 to 200,000 shares will receive gift boxes valued at 500 yuan [3] - The activity will take place from January 28 to January 30, and shareholders must apply personally or designate a representative to claim their gifts [3] Group 3 - Other companies like Shouxiangu, Haoxiangni, and Suyanjingshen are also engaging in similar shareholder reward activities, offering exclusive products at discounted prices [2][4][5] - Shouxiangu is providing special purchase options for its products during the Spring Festival, while Haoxiangni is offering exclusive gift boxes at reduced prices for shareholders [4] - Suyanjingshen is celebrating its 10th anniversary by offering free experience gift boxes to shareholders who provide feedback on the company's development [5] Group 4 - Furi Co.'s main business includes home textile and new materials, with a reported revenue of 3.841 billion yuan for the first three quarters of 2025, a decrease of 4.45% year-on-year, and a net profit of 296 million yuan, down 12.05% year-on-year [3]

Summary of Key Points from Conference Call Industry Overview - The focus is on the second-generation probiotics, specifically the AKK strain, which shows stronger intervention effects in metabolic diseases and weight loss compared to first-generation probiotics found in yogurt and pickles [1][3][11]. Core Insights and Arguments - **Safety Concerns**: The safety of AKK strains remains a challenge, with regulatory bodies cautious about their approval for use in dietary supplements [1][6][10]. - **International Developments**: Companies like Pendulum and Silex Health are leading in the AKK space, with Pendulum developing diabetes management products and Silex Health focusing on inactivated AKK raw materials, both securing necessary certifications [1][5][7]. - **Domestic Challenges**: Domestic companies face patent barriers, insufficient high-quality clinical data, and challenges in industrialization, particularly in the core patent areas of AKK strains [1][8]. - **Regulatory Landscape**: In China, dietary supplements must meet strict safety regulations, with the AKK strain classified as a novel food in the EU, where only inactivated forms are approved [1][10][12]. Additional Important Content - **Market Dynamics**: The domestic market is seeing companies like Shang En Kang actively pursuing AKK research and commercialization, having achieved dual-track certification for both live and inactivated strains [1][11]. - **Cross-Border E-commerce Regulations**: Stricter regulations are being implemented for cross-border health products, with increased scrutiny on origin certification and ingredient regulation [1][14][19]. - **Clinical Trials and Patent Applications**: Clinical trials typically take 1.5 to 2 years, while patent applications can take 3 to 5 years, indicating a significant lead time for companies in this sector [1][9]. - **Consumer Awareness**: Consumers are encouraged to evaluate probiotic products based on preservation numbers, quality of clinical trials, and safety assessments [1][17][18]. Market Players and Product Launches - **Current Market Players**: Brands like Ruyuchen, Niu Yibei, and Baicaoyuan have launched AKK-related products, utilizing various strains from different manufacturers [1][16][20]. - **Future Prospects**: While the potential for AKK is significant, large traditional companies remain cautious, with most new entrants being smaller players [1][21]. Conclusion - The AKK strain represents a promising area in the probiotic market, but companies must navigate complex regulatory environments, safety concerns, and competitive challenges to succeed in both domestic and international markets [1][22][23].